Neil Varshneya

Q: What is Neil Varshneya email address?

Email Neil Varshneya at neil.varshneya@fda.gov. This email is the most updated Neil Varshneya email found in 2026.

Q: How to contact Neil Varshneya?

To contact Neil Varshneya send an email to neil.varshneya@fda.gov. (updated on November 04, 2024)

Senior Pharmacologist at FDA | Silver Spring, Maryland, United States

About Neil Varshneya

Neil Varshneya is a dedicated pharmacologist at the FDA, where he plays a pivotal role in the evaluation and regulation of emerging drugs of abuse, particularly focusing on substances like fentanyl analogs and semi-synthetic cannabinoids. His expertise lies in the design and execution of rigorous scientific evaluations, leveraging both preclinical models and human studies to assess the safety and efficacy of new pharmacological agents. At the FDA's Center for Drug Evaluation and Research (CDER), within the Office of Controlled Substances (OCD) and the Controlled Substance Staff (CSS), Neil is instrumental in guiding regulatory submissions, including New Drug Applications (NDAs), ensuring that innovative therapies meet the highest standards of safety and efficacy.

Neil's proficiency in advanced methodologies, such as binding affinity and functional activity assays, enables him to contribute significantly to the understanding of drug dependence and the pharmacodynamics of novel compounds. His experience with self-administration and drug discrimination studies further enhances his ability to assess the potential for abuse and addiction associated with new drugs. In addition to his technical skills, Neil is adept in project management and program management, utilizing tools like R and Python for data analysis and modeling, which streamlines the evaluation process and enhances the robustness of findings.

As a health scientist administrator, Neil collaborates with multidisciplinary teams to ensure that scientific evaluations are not only thorough but also aligned with regulatory frameworks. His commitment to advancing public health through the responsible assessment of new drugs positions him as a key player in the ongoing battle against substance abuse and the development of safer therapeutic options. Through his work, Neil Varshneya exemplifies the critical intersection of science, regulation, and public health in the ever-evolving landscape of pharmacology.

Neil Varshneya Work